Diagnostic value of salivary CRP and IL-6 in patients undergoing anti-TNF-alpha therapy for rheumatic disease.

Dorota SikorskaZofia OrzechowskaRafał RutkowskiAnna PrymasMarta Mrall-WechtaDaria Bednarek-HatlińskaMagdalena RoszakAnna SurdackaWłodzimierz SamborskiJanusz Witowski

Published in: Inflammopharmacology (2018)

Salivary CRP but not IL-6 could be of potential use for monitoring the rheumatic disease activity.

Keyphrases

rheumatoid arthritis
disease activity
patients undergoing
rheumatoid arthritis patients
ankylosing spondylitis
systemic lupus erythematosus
juvenile idiopathic arthritis
human health
risk assessment